Switch to:
More From Other Websites
VIVUS Announces Issuance of Two Additional U.S. Patents for Qsymia Apr 21 2015
VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 21 2015
VIVUS Announces Issuance of Two Additional U.S. Patents for Qsymia Apr 21 2015
VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers Apr 17 2015
VIVUS Responds to Teva's Filing for Qsymia Generics - Analyst Blog Apr 16 2015
VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 16 2015
VIVUS Files Lawsuit Against Teva for Infringement of Qsymia Patents Apr 15 2015
VIVUS Files Lawsuit Against Teva for Infringement of Qsymia Patents Apr 15 2015
VIVUS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Apr 14 2015
Pharmalot…Pharmalittle…Good Morning: We're Catching up on Eisai, HepC Research, Pfizer and Ebola Apr 10 2015
VIVUS to Present at Upcoming Investor Conference Apr 10 2015
VIVUS to Present at Upcoming Investor Conference Apr 10 2015
Eisai Drops On US Job Cuts, Still A Stunning Run On Alzheimer's Drug With Biogen Apr 10 2015
Japanese Drug Company Eisai to Cut 25% of U.S. Jobs Apr 09 2015
Vivus Goes on a Diet: Sales Reps are Cut, but Will FDA Help Save Money? Apr 02 2015
VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 30 2015
VIVUS Announces Operational Update Mar 30 2015
VIVUS Announces Operational Update Mar 30 2015
A Look at Pharma Company Dermira's Performance Mar 27 2015
Ahead of the Bell: Orexigen shares rise Mar 27 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK